SELLAS Life Sciences Group, Inc.
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunot…
Biotechnology
US, New York [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
SELLAS Life Sciences Group, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDSELLAS Life Sciences Group, Inc. can't present revenue by segment